United Therapeutics: brands it owns and its ownership tree
United Therapeutics (NASDAQ: UTHR) is a publicly listed company headquartered in Silver Spring, United States that owns 5 consumer brands.[1]
United Therapeutics is a US biotechnology company. Its 2025 Form 10-K reports sales of pulmonary arterial hypertension medicines and of Unituxin.
-
brands owned
-
1
categories
-
0
acquisitions recorded
-
0
subsidiaries recorded
Company facts
- Legal name
- United Therapeutics Corporation
- Headquarters
- 🇺🇸 Silver Spring, United States
- Type
- publicly listed company · all publicly listed company owners
- Founded
- 1996
- Tickers
- NASDAQ: UTHR
- Identifiers
- SEC CIK 0001082554
- Last verified
- · 1 sources
Brands United Therapeutics owns
5 brands in 1 category.
Drug makers (5)
Full list of 5 brands with sources · Interactive ownership tree
Ownership structure
No company is recorded as controlling United Therapeutics.
Financials and filings
United Therapeutics financial history
Headline figures from United Therapeutics's annual reports filed with the US Securities and Exchange Commission, in USD as reported, fiscal years ending 2020–2025. Revenue moved from $1.48bn to $3.18bn, an average of 16.5% a year (calculated).
| Fiscal year ended | Revenue | Operating income | Operating margin | Net income | Total assets | Long-term debt | Filing |
|---|---|---|---|---|---|---|---|
| $3.18bn | $1.49bn | 46.9% | $1.33bn | $7.88bn | — | 10-K | |
| $2.88bn | $1.38bn | 47.9% | $1.2bn | $7.36bn | — | 10-K | |
| $2.33bn | $1.18bn | 50.9% | $984.8m | $7.17bn | — | 10-K | |
| $1.94bn | $979.7m | 50.6% | $727.3m | $6.04bn | — | 10-K | |
| $1.69bn | $555.9m | 33.0% | $475.8m | $5.17bn | — | 10-K | |
| $1.48bn | $593.6m | 40.0% | — | $4.62bn | — | 10-K |
Source: SEC XBRL company facts. A dash means the company did not report that line in a form we could read. Figures for a year can be restated in a later filing; the latest filing's number is shown.
United Therapeutics SEC filings
The documents behind the figures on this page, as listed in the SEC's EDGAR index. Each links to the filing itself.
Annual reports
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
Proxy statements
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
Recent current and quarterly reports
| Filed | Form | What it declares |
|---|---|---|
| 8-K | Results of operations and financial condition | |
| 10-Q | Quarterly report | |
| 8-K | Other events | |
| 8-K | Other events | |
| 8-K | Entry into a material agreement; Regulation FD disclosure | |
| 8-K | Results of operations and financial condition | |
| 10-Q | Quarterly report | |
| 8-K | Departure or appointment of directors or officers; Regulation FD disclosure | |
| 8-K | Departure or appointment of directors or officers; Results of a shareholder vote | |
| 8-K | Results of operations and financial condition | |
| 10-Q | Quarterly report | |
| 8-K | Other events | |
| 8-K | Entry into a material agreement; Regulation FD disclosure | |
| 8-K | Regulation FD disclosure |
United Therapeutics in the global legal-entity registry
The Global Legal Entity Identifier Foundation (GLEIF) keeps an open register of legal entities. Each entity reports its own parents. We show it as a cross-check on the ownership recorded on this page, which is built from filings.
- Legal entity identifier (LEI)
- 5299005C4HZL4UWROC14
- Registered name
- UNITED THERAPEUTICS CORPORATION (US)
- Registration status
- Lapsed · record updated 10 November 2021
- Parent
- None named: it reports that it has no parent that consolidates its accounts.
- Retrieved
- · GLEIF record (JSON)
Frequently asked questions
What brands does United Therapeutics own?
United Therapeutics owns 5 consumer brands tracked here, including Orenitram, Remodulin, Unituxin, Adcirca and Tyvaso.
Is United Therapeutics an American company?
Yes. United Therapeutics is headquartered in Silver Spring, United States and was founded in 1996.
Who owns United Therapeutics?
United Therapeutics is a publicly listed company owned by its shareholders; it trades as UTHR on the NASDAQ.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] United Therapeutics Corporation Annual Report on Form 10-K filed 2026-02-25 — SEC EDGAR, SEC Form 10-K, published 25 February 2026; retrieved 8 November 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.